Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.
about
Antiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignanciesAntiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignanciesUpdate on human herpesvirus 6 biology, clinical features, and therapyHuman herpesvirus 6 infection in hematopoietic stem cell transplant patientsHHV-6 reactivation and associated sequelae after hematopoietic cell transplantationDiagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation.Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cellsRoseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.Human Herpesvirus-6 Pneumonitis around the Engraftment of Cord Blood Transplantation following Foscarnet Prophylaxis in a Patient with Acute Leukemia.Human herpesvirus 6: relevance of infection in the immunocompromised host.Analysis of ganciclovir-resistant human herpesvirus 6B clinical isolates using quenching probe PCR methodology.Rapid diagnosis of human herpesvirus 6 infection by a novel DNA amplification method, loop-mediated isothermal amplification.Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?A Simple Proteomics-Based Approach to Identification of Immunodominant Antigens from a Complex Pathogen: Application to the CD4 T Cell Response against Human Herpesvirus 6BClinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.Beta-herpesviruses in febrile children with cancerPrevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience.Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.Copy numbers of telomeric repeat sequences of human herpesvirus 6B in clinical isolates: possibility of mixed infections.Contemporary infectious exanthems: an update.Analysis of human herpes virus 6 infections with a quantitative, standardized, commercial kit in pediatric stem cell transplant recipients after transplantation.Virus reactivations after autologous hematopoietic stem cell transplantation detected by multiplex PCR assay.Cycling probe-based real-time PCR for the detection of Human herpesvirus 6A and B.Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation.Human herpesvirus-6 viremia is not associated with poor clinical outcomes in children following allogeneic hematopoietic cell transplantation.Virological analysis of inherited chromosomally integrated human herpesvirus-6 in three hematopoietic stem cell transplant patients.Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review From the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT.Human herpesvirus type 6 DNAemia and infection following allogeneic stem cell transplantation with a focus on long-term outcome.Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses.Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.Development of a microwell adapted immunoblot system with recombinant antigens for distinguishing human herpesvirus (HHV)6A and HHV6B and detection of human cytomegalovirus.Rare viral infections in children receiving hemopoietic stem cell transplant.High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia.Myelitis associated with human herpes virus 6 (HHV-6) after allogeneic cord blood transplantation.Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients.Atypical exanthems related to human herpesvirus-6 reactivations in transplant recipients.Development of quantitative RT-PCR assays for detection of three classes of HHV-6B gene transcripts.
P2860
Q24234350-ED4591C4-12CF-423B-8857-72F5BFA22CDFQ24241918-8D15159E-24F3-4055-8D78-4E99FFF480F9Q24557543-EE917393-DFCA-43C0-9C58-A92C533F848AQ28246906-96713B3B-FB1F-44CF-A2AD-91DB21AE8A02Q28727925-F6837D09-988F-4870-9118-1CD5EFE1FC0AQ30883059-BFFDCC87-27F6-471B-B830-AC195DE2E305Q33301426-F264A6F3-F21D-4666-A018-D0C62A7EC7C0Q34537814-94AE30BC-BC93-4533-AF50-FC7548D2A627Q35012438-40D400D2-DD56-4C39-9D37-2D4B531EBDEBQ35064314-06980435-AB16-4606-86BC-7D03837B5651Q35385659-7EE82BD9-E85D-4AF7-B390-213C244FEE25Q35551852-9B2E6DCA-FE2D-4D3D-8AC6-0D1F6674ED11Q35774717-7CB922C1-C1E1-4994-9094-9A3E9D63FEB9Q35850475-5F07F2D5-8452-4006-9C04-E87FB03E01F2Q36095851-9D614010-DBAD-4537-B974-D0450BD82F47Q36944956-A6003543-BB67-4605-9034-44E864DBA881Q37177116-C92262E2-5DB1-4E4A-8C3F-453B279159C1Q37276889-257B9494-6FBB-49A6-AB80-BE341137D97EQ37426542-C9C9BB64-D5EC-4308-9A2C-FE04BC446835Q37546237-18598722-CD38-408B-8425-E3421D88F3A8Q38795858-25066D32-3AE3-4817-B53D-33592309D8D7Q40213229-221E10FB-501C-4073-900C-0DC4B5301AEAQ40629756-3A4730EC-AB87-4859-8F58-B0203D445BD6Q40766749-81CF64BE-D773-4DBC-9F3E-0B48B949729AQ40849677-8A0F17EA-E272-45CD-9195-FDBAFD9495A9Q41021152-86E2037D-9BCA-485F-A4EF-F3284E6BBD73Q41585310-B05ABE71-08DE-4485-9468-1C95847F70F3Q41995096-8A1C079A-1B75-4E91-B1C1-4BBE6538691AQ42272500-07B905F7-B6BF-4EF2-9EB0-F182F555FFA7Q43636855-0FE871B7-CAFC-4E49-9C4E-92FD4ECC7E7FQ43971471-1934E2BF-3F5C-4679-8EA9-247EB0710610Q44189939-0B89B2B0-633D-4739-8D04-6224A81797D7Q44356190-B9F5A8C1-C2B3-4443-86A3-3E92B53ED50BQ44920798-694328D6-29E2-483E-AEC5-4CEC9CF57213Q45368979-7146E768-993B-474D-8BDF-F8078E23F76AQ45406137-D7754168-4E48-4B56-9837-DC29B95A91C6Q47436824-F607B14C-03C0-4C92-9280-C16C2494CABAQ47733733-3BA3686A-AC9F-4128-B207-25B31A43ECA0Q50863623-F9B2FE15-445A-42CA-A4A6-905B53C6813AQ54299593-89538CB7-25E1-4431-9383-09C287B805E5
P2860
Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Human herpesvirus 6 viremia in ...... cal features and risk factors.
@en
Human herpesvirus 6 viremia in ...... cal features and risk factors.
@nl
type
label
Human herpesvirus 6 viremia in ...... cal features and risk factors.
@en
Human herpesvirus 6 viremia in ...... cal features and risk factors.
@nl
prefLabel
Human herpesvirus 6 viremia in ...... cal features and risk factors.
@en
Human herpesvirus 6 viremia in ...... cal features and risk factors.
@nl
P2093
P356
P1476
Human herpesvirus 6 viremia in ...... cal features and risk factors.
@en
P2093
Kazuko Kudo
Keizo Horibe
Kyoko Suzuki
Masahiro Ohashi
Masaru Ihira
Sadao Suga
Seiji Kojima
Takaharu Matsuyama
Tetsushi Yoshikawa
P304
P356
10.1086/339411
P407
P577
2002-03-19T00:00:00Z